Gyre Therapeutics (GYRE) Interest & Investment Income (2010 - 2023)
Gyre Therapeutics' Interest & Investment Income came in at $47,000 for Q3 2023, down 83.3% from $282,000 a year earlier and down 35.6% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Interest & Investment Income (2010 - 2023) Analysis & Trends
Over the trailing twelve months to Sep 30, 2023, Gyre Therapeutics reported Interest & Investment Income of $384,000, down 28.0% year-over-year; for FY2022, it came in at $717,000.
- Interest & Investment Income carries a five-year compound annual growth rate of 22.4% (FY2017 to FY2022).
- Going back by year, Interest & Investment Income was -$39,000 in FY2021, $1.13 million in FY2020 (-46.2%), $2.1 million in FY2019 (-44.3%) and $3.77 million in FY2018.
- The Q3 2023 figure represents the lowest quarterly Interest & Investment Income since Q4 2021.
- Year-over-year, Interest & Investment Income has declined for three consecutive quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2020 (growth of 60.9%), and the weakest in Q3 2020 (a decline of 86.3%).
- Business Quant data shows GYRE's Interest & Investment Income at $73,000 (Q2 2023), $96,000 (Q1 2023) and $168,000 (Q4 2022) in the three quarters before Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 73,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | 168,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Dec 31, 2021 | -16,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -14,000.00 |
| Dec 31, 2020 | -66,000.00 |
| Sep 30, 2020 | 67,000.00 |
| Jun 30, 2020 | 113,000.00 |
| Mar 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 377,000.00 |
| Sep 30, 2019 | 489,000.00 |
| Jun 30, 2019 | 601,000.00 |
| Mar 31, 2019 | 631,000.00 |
| Dec 31, 2018 | 847,000.00 |
| Sep 30, 2018 | 651,000.00 |
API Access
Gyre Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();